Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 5/20 | 0.54 |
| ▸ | MMP12 | P39900 | 5/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
| ▸ | BCR | P11274 | 1/20 | 0.43 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.39 |
| ▸ | ULK1 | O75385 | 1/20 | 0.39 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34470141 | 0.90 | MMP12 (0.45) | ABL1MMP12KDRMMP13 | |
| SCHEMBL34469998 | 0.85 | KDR (0.42) | ABL1KDR | |
| SCHEMBL34470231 | 0.85 | RAB9A (0.45) | ABL1MMP12KDRMMP13ADORA3 | |
| SCHEMBL34469593 | 0.83 | KDR (0.43) | ABL1KDRULK1MAPK1NPC1 | |
| SCHEMBL25352282 | 0.79 | ALDH1A1 (0.41) | ABL1KDRCYP1A2 | |
| SCHEMBL34470025 | 0.79 | ICAM1 (0.40) | ABL1KDRNPC1RAB9AL3MBTL1 | |
| SCHEMBL25351483 | 0.75 | AXL (0.49) | ABL1KDRBCRADORA3L3MBTL1 | |
| SCHEMBL34470178 | 0.74 | IKBKE (0.43) | KDRCYP1A2NPC1RAB9AL3MBTL1 | |
| SCHEMBL5128240 | 0.74 | RXFP1 (0.56) | ABL1BCRMRGPRX4SCN10AADORA3 | |
| SCHEMBL34469508 | 0.73 | LDHA (0.41) | ABL1KDRMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090477-A1 | HELICASE INHIBITORS AND USES THEREOF | KIMIA THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |